BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25788263)

  • 1. Cbl-b inhibits P-gp transporter function by preventing its translocation into caveolae in multiple drug-resistant gastric and breast cancers.
    Zhang Y; Qu X; Teng Y; Li Z; Xu L; Liu J; Ma Y; Fan Y; Li C; Liu S; Wang Z; Hu X; Zhang J; Liu Y
    Oncotarget; 2015 Mar; 6(9):6737-48. PubMed ID: 25788263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E3 Ubiquitin Ligase Cbl-b Prevents Tumor Metastasis by Maintaining the Epithelial Phenotype in Multiple Drug-Resistant Gastric and Breast Cancer Cells.
    Xu L; Zhang Y; Qu X; Che X; Guo T; Cai Y; Li A; Li D; Li C; Wen T; Fan Y; Hou K; Ma Y; Hu X; Liu Y
    Neoplasia; 2017 Apr; 19(4):374-382. PubMed ID: 28334634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of P-glycoprotein-mediated multi-drug resistance by the E3 ubiquitin ligase Cbl-b in human gastric adenocarcinoma cells.
    Zhang Y; Qu X; Hu X; Yang X; Hou K; Teng Y; Zhang J; Sada K; Liu Y
    J Pathol; 2009 Jun; 218(2):248-55. PubMed ID: 19274672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of E3 ubiquitin ligase Cbl proteins in β-elemene reversing multi-drug resistance of human gastric adenocarcinoma cells.
    Zhang Y; Mu XD; Li EZ; Luo Y; Song N; Qu XJ; Hu XJ; Liu YP
    Int J Mol Sci; 2013 May; 14(5):10075-89. PubMed ID: 23665906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibitory effect of pseudolaric acid B on gastric cancer and multidrug resistance via Cox-2/PKC-α/P-gp pathway.
    Sun Q; Li Y
    PLoS One; 2014; 9(9):e107830. PubMed ID: 25250794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 7-O-geranylquercetin contributes to reverse P-gp-mediated adriamycin resistance in breast cancer.
    Zhang E; Liu J; Shi L; Guo X; Liang Z; Zuo J; Xu H; Wang H; Shu X; Huang S; Zhang S; Kang X; Zhen Y
    Life Sci; 2019 Dec; 238():116938. PubMed ID: 31593704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTRF/cavin-1 is essential for multidrug resistance in cancer cells.
    Yi JS; Mun DG; Lee H; Park JS; Lee JW; Lee JS; Kim SJ; Cho BR; Lee SW; Ko YG
    J Proteome Res; 2013 Feb; 12(2):605-14. PubMed ID: 23214712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Elemene inhibits the metastasis of multidrug-resistant gastric cancer cells through miR-1323/Cbl-b/EGFR pathway.
    Deng M; Liu B; Song H; Yu R; Zou D; Chen Y; Ma Y; Lv F; Xu L; Zhang Z; Lv Q; Yang X; Che X; Qu X; Liu Y; Zhang Y; Hu X
    Phytomedicine; 2020 Apr; 69():153184. PubMed ID: 32199253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C; Guan X; Xue H; Wang P; Wang M; Gai X
    Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The E3 ubiquitin ligase Cbl-b inhibits tumor growth in multidrug-resistant gastric and breast cancer cells.
    CHe X; Zhang Y; Qu X; Guo T; Ma Y; Li C; Fan Y; Hou K; Cai Y; Yu R; Zhou H; He X; Wu H; Liu Y; Xu L
    Neoplasma; 2017; 64(6):887-892. PubMed ID: 28895413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon regulatory factor-1 reverses chemoresistance by downregulating the expression of P-glycoprotein in gastric cancer.
    Yuan J; Yin Z; Tan L; Zhu W; Tao K; Wang G; Shi W; Gao J
    Cancer Lett; 2019 Aug; 457():28-39. PubMed ID: 31078735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of P-glycoprotein/cellular prion protein interaction in multidrug-resistant breast cancer cells treated with paclitaxel.
    Li QQ; Cao XX; Xu JD; Chen Q; Wang WJ; Tang F; Chen ZQ; Liu XP; Xu ZD
    Cell Mol Life Sci; 2009 Feb; 66(3):504-15. PubMed ID: 19099191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.
    Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y
    Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rack1 mediates Src binding to drug transporter P-glycoprotein and modulates its activity through regulating Caveolin-1 phosphorylation in breast cancer cells.
    Fan Y; Si W; Ji W; Wang Z; Gao Z; Tian R; Song W; Zhang H; Niu R; Zhang F
    Cell Death Dis; 2019 May; 10(6):394. PubMed ID: 31113938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midkine confers Adriamycin resistance in human gastric cancer cells.
    Xu YY; Mao XY; Song YX; Zhao F; Wang ZN; Zhang WX; Xu HM; Jin F
    Tumour Biol; 2012 Oct; 33(5):1543-8. PubMed ID: 22576950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
    Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D
    J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
    Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
    Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of different heating methods combined with neferine on the expressions of γH2AX and mdr-1/P-gp in MCF-7/Adr breast cancer cells].
    Huang C; Cao P; Xie Z; Zhu H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 36(4):317-22. PubMed ID: 21566283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shenmai injection suppresses multidrug resistance in MCF-7/ADR cells through the MAPK/NF-κB signalling pathway.
    Yang L; Zhang C; Chen J; Zhang S; Pan G; Xin Y; Lin L; You Z
    Pharm Biol; 2020 Dec; 58(1):276-285. PubMed ID: 32251615
    [No Abstract]   [Full Text] [Related]  

  • 20. Quercetin reversed MDR in breast cancer cells through down-regulating P-gp expression and eliminating cancer stem cells mediated by YB-1 nuclear translocation.
    Li S; Zhao Q; Wang B; Yuan S; Wang X; Li K
    Phytother Res; 2018 Aug; 32(8):1530-1536. PubMed ID: 29635751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.